The Wall Street Journal: Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion
The Wall Street Journal: Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion
193
views
Pfizer Inc. is in talks to acquire biotech Seagen Inc., according to people familiar with the matter, the latest potential deal for a big drug company aimed...
Pfizer Inc. is in talks to acquire biotech Seagen Inc., according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a promising class of targeted cancer therapies.

Comments

https://stocktradingwebsites.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!